Direava secures Japanese approval for CYNOSURA surgical video-recognition software
Direava announced Japanese manufacturing and marketing approval for CYNOSURA, an AI medical-device program that identifies and highlights recurrent laryngeal nerves during robot-assisted oesophageal cancer surgery.
Evidence notes
- Japan's Ministry of Health, Labour and Welfare granted approval on 9 December 2025 under approval number 30700BZX00326000.
- CYNOSURA processes surgical video in real time to identify and highlight the left and right recurrent laryngeal nerves.
- The approved indication supports recognition during robot-assisted surgery for malignant oesophageal tumours.
Company context
Direava develops vision-language artificial intelligence for surgery. Its software interprets operative video and clinical context to support workflow understanding, documentation and decision assistance, creating an intelligence layer that can be integrated with surgical imaging and robotic platforms.